- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroendocrine Neoplasms in Spain
Total 6041 results
-
Grupo Espanol de Tumores NeuroendocrinosActive, not recruitingNeuroendocrine Tumors | Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine TumorSpain
-
Boehringer IngelheimRecruitingNeuroendocrine NeoplasmsUnited States, Spain, Germany, Japan
-
Fundación de investigación HMSyntax for Science, S.LRecruitingNeuroendocrine Tumours (NET) | Neuroendocrine Carcinomas (NEC)Spain
-
Grupo Espanol de Tumores NeuroendocrinosCompletedNeuroendocrine Tumors | Neuroendocrine Neoplasm of LungSpain
-
Grupo Espanol de Tumores NeuroendocrinosCompleted
-
Grupo Espanol de Tumores NeuroendocrinosCompleted
-
Hoffmann-La RocheWithdrawn
-
Advanced Accelerator ApplicationsActive, not recruitingPheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine TumorsUnited States, Spain, France, Poland, United Kingdom
-
IpsenCompleted
-
Grupo Espanol de Tumores NeuroendocrinosPfizer; Apices Soluciones S.L.CompletedPancreatic Neuroendocrine Tumour MetastaticSpain
-
AI Labs Group S.LHospital de Basurto; Osakidetza; Hospital de Cruces; Servicio Vasco de Salud Osakidetza...RecruitingMelanoma | Melanoma, SkinSpain
-
Sociedad Española de Oncología QuirúrgicaSysmex EspañaUnknownSentinel Lymph Node | Melanoma StageSpain
-
Hospital Universitario Virgen MacarenaRecruiting
-
Grupo Espanol de Tumores NeuroendocrinosRecruitingGastroenteropancreatic Neuroendocrine TumorSpain
-
Novartis PharmaceuticalsCompletedNeoplasms | Kidney Neoplasms | Breast Neoplasms | Pancreatic Neuroendocine Neoplasms (pNETs)France, Germany, United States, Netherlands, Italy, Spain, United Kingdom, Hong Kong, Hungary
-
Advanced Accelerator ApplicationsActive, not recruitingNeuroendocrine TumorsUnited Kingdom, Portugal, Spain, France, United States
-
Grupo Espanol de Tumores NeuroendocrinosCompletedPancreatic Neuroendocrine TumorsSpain
-
Aduro Biotech, Inc.Terminated
-
eTheRNA immunotherapiesTerminated
-
Anna CrucetaUnknownMelanoma | Breast Cancer | Head Cancer | Neck CancerSpain
-
Hospital Universitario Virgen de la ArrixacaRecruitingCutaneous Melanoma | Anatomical Pathological ConditionSpain
-
Advanced Accelerator ApplicationsActive, not recruitingGastro-enteropancreatic Neuroendocrine TumorSpain, United States, United Kingdom, France, Canada, Germany, Netherlands, Italy, Korea, Republic of
-
José María Piulats RodríguezInstituto de Salud Carlos IIINot yet recruitingUveal Melanoma, MetastaticSpain
-
Novartis PharmaceuticalsCompletedCarcinoma | Neuroendocrine | Advanced and Metastatic Silent Neuro-Endocrine Tumors | Non Functioning Neuroendocrine Tumors (NETs) | Non Syndromic Neuroendocrine Tumors | Carcinoids | Non FunctioningSweden, Italy, Germany, United Kingdom, Spain, France, Netherlands, Poland
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma | Neuroendocrine NeoplasmsUnited States, Belgium, Spain, Korea, Republic of, United Kingdom, Germany, Japan, China, Taiwan, France, Portugal, Bulgaria
-
Philogen S.p.A.Immatics Biotechnologies GmbHTerminatedMerkel Cell CarcinomaGermany, Austria, Denmark, France, Spain, United Kingdom
-
Grupo Espanol de Tumores NeuroendocrinosRoche Pharma AG; IpsenActive, not recruitingAdenocarcinoma | Neuroendocrine Tumor | Pheochromocytoma | Paraganglioma | Anaplastic Thyroid CancerSpain
-
HutchmedActive, not recruitingNeuroendocrine Tumours | Neuroendocrine Tumour of the Lung | Small Intestinal NETSpain, France, United States, United Kingdom, Norway, Germany, Italy
-
BioNTech US Inc.RecruitingMetastatic Melanoma | Unresectable MelanomaBelgium, Netherlands, Spain
-
GlaxoSmithKlineTerminated
-
Novartis PharmaceuticalsCompletedNeuroendocrine Carcinoma of the Lung and ThymusItaly, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
Achilles Therapeutics UK LimitedRecruiting
-
Novartis PharmaceuticalsCompletedPancreatic Neuroendocrine Tumors (pNET)France, Spain, Belgium, Germany, Italy, United Kingdom, Austria, Netherlands, United States
-
Grupo Espanol de Tumores NeuroendocrinosMFAR; ITM Oncologics GmbHRecruitingThymus Neoplasms | Neuroendocrine Tumors | Lung Neuroendocrine NeoplasmSpain, Italy, France
-
IpsenCompletedGastrointestinal Neuroendocrine TumoursSpain, Portugal
-
Institut Català d'OncologiaCompletedLocally Advanced or Metastatic MelanomaSpain
-
Hoffmann-La RocheRecruitingSmall Cell Lung Cancer | Neuroendocrine CarcinomaUnited States, Japan, Denmark, Spain, Poland
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
IpsenTerminatedNeuroendocrine Tumors in LungCanada, United States, Germany, France, United Kingdom, Netherlands, Spain, Denmark, Italy, Austria, Poland
-
Highlight TherapeuticsMerck Sharp & Dohme LLCActive, not recruiting
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingColon Cancer | Malignant Neoplasm | Colon Neoplasm, Malignant | Colon Neoplasm | Colon NeoplasiaSpain
-
Camurus ABActive, not recruitingGastro-enteropancreatic Neuroendocrine TumorUnited States, Belgium, Spain, Netherlands, France, Germany, Israel, Italy, Canada, Australia, Romania, Hungary
-
ITM Solucin GmbHRecruitingNeuroendocrine TumorsUnited States, United Kingdom, Australia, France, Italy, Netherlands, Spain, Germany, Sweden, India
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
IpsenTerminatedPancreatic Neuroendocrine TumorSpain, Portugal
-
Novartis PharmaceuticalsTerminatedPancreatic Neuroendocrine Tumors (pNET)United Kingdom, Spain, Netherlands, Italy, Russian Federation, France, Switzerland, United States
-
Bristol-Myers SquibbWithdrawnMelanoma | Urothelial CarcinomaGermany, Spain
-
PfizerCompletedWell-differentiated Pancreatic Neuroendocrine TumorUnited States, China, Czechia, India, Japan, South Africa, Slovakia, France, Norway, Romania, Australia, Belgium, Hungary, Italy, Spain
-
Grupo Español Multidisciplinar de MelanomaMFARWithdrawnMetastatic Cancer | Uveal MelanomaSpain